Scott Cathcart, co-founder and CEO of Seven-10 Pharmaceuticals, was interviewed at Benzinga’s Cannabis Capital Conference. The company recently got its cannabis pharmaceutical license and is now sending shipments to Brazil, representing a large expansion into a big market. They are also expanding into other international markets in addition to having operations in the United States. Cathcart shared that with international regulations always changing, being flexible is essential to succeeding in the industry.
Watch Exclusive Footage Here
Interested in learning more about the Benzinga Cannabis Capital Conference? Get more information here
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.